Literature DB >> 19818910

Intrathecal administration of GABA agonists in the vegetative state.

Takaomi Taira1.   

Abstract

Gamma aminobutyric acid (GABA) is an inhibitor neurotransmitter that plays many important roles in the central nervous system. Because the half-life time of GABA is very short in vivo, GABA itself is not used for clinical practice. An analogue of GABA, baclofen, is an agonist of GABA-B receptor, and has very strong antispastic effect by acting to the posterior horn of the spinal cord. However, baclofen poorly crosses through the blood brain barrier, and the antispastic effect is modest when administered orally. Therefore, direct continuous infusion of small doses of baclofen into the cerebrospinal fluid (intrathecal baclofen therapy, ITB) has become an established treatment for control of otherwise intractable severe spasticity. Spasticity is clinically defined as hypertonic state of the muscles with increased tendon reflexes, muscles spasm, spasm pain, abnormal posture, and limitation of involuntary movements. Spasticity is a common symptom after damage mainly to the pyramidal tract system in the brain or the spinal cord. Such damage is caused by traumatic brain injury, stroke, spinal cord injury, multiple sclerosis, and so on. Patients in persistent vegetative state (PVS) usually have diffuse and widespread damage to the brain, spasticity is generally seen in such patients. Control of spasticity may become important in the management of PVS patients in terms of nursing care, pain relief, and hygiene, and ITB may be indicated. Among PVS patients who had ITB to control spasticity, sporadic cases of dramatic recovery from PVS after ITB have been reported worldwide. The mechanism of such recovery of consciousness is poorly understood, and it may simply be a coincidence. On the other hand, electrical spinal cord stimulation (SCS) has been tried for many years in many patients in PVS, and some positive effects on recovery of consciousness have been reported. SCS is usually indicated for control of neuropathic pain, but it has also antispastic effect. The mechanism of SCS on pain is known to be mediated through the spinal GABA neuronal system. Thus, ITB and SCS have a common background, spinal GABA neuronal mechanism. The effect of GABA agonists on recovery of consciousness is not yet established, but review of such case studies becomes a clue to solve problems in PVS, and there may be hidden serendipity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818910     DOI: 10.1016/S0079-6123(09)17721-X

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  12 in total

1.  Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity.

Authors:  Casey Melissa Berman; Melissa Ann Eppinger; Catherine Anne Mazzola
Journal:  Childs Nerv Syst       Date:  2014-11-16       Impact factor: 1.475

Review 2.  Effects of intrathecal baclofen therapy in subjects with disorders of consciousness: a reappraisal.

Authors:  Raffaele Nardone; Luca Sebastianelli; Francesco Brigo; Stefan Golaszewski; Eugen Trinka; Elke Pucks-Faes; Leopold Saltuari; Viviana Versace
Journal:  J Neural Transm (Vienna)       Date:  2020-07-24       Impact factor: 3.575

Review 3.  Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility?

Authors:  Rosella Ciurleo; Placido Bramanti; Rocco Salvatore Calabrò
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 4.  Awakenings and awareness recovery in disorders of consciousness: is there a role for drugs?

Authors:  Francesca Pistoia; Elisa Mura; Stefano Govoni; Massimo Fini; Marco Sarà
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

Review 5.  Intrathecal baclofen: effects on spasticity, pain, and consciousness in disorders of consciousness and locked-in syndrome.

Authors:  Francesca Pistoia; Simona Sacco; Marco Sarà; Marco Franceschini; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2015-01

Review 6.  Disorders of consciousness after acquired brain injury: the state of the science.

Authors:  Joseph T Giacino; Joseph J Fins; Steven Laureys; Nicholas D Schiff
Journal:  Nat Rev Neurol       Date:  2014-01-28       Impact factor: 42.937

7.  Selected Gamma Aminobutyric Acid (GABA) Esters may Provide Analgesia for Some Central Pain Conditions.

Authors:  Joel S Goldberg
Journal:  Perspect Medicin Chem       Date:  2010-08-03

8.  Intrathecal baclofen therapy in severe head injury, first time in Nepal, a technique suitable for underdeveloped countries.

Authors:  Prabin Shrestha; Hridayesh Malla; Basant Pant; Takaomi Taira
Journal:  Asian J Neurosurg       Date:  2011-01

9.  Selective dorsal rhizotomy for spastic diplegia secondary to stroke in an adult patient.

Authors:  Melissa Ann Eppinger; Casey Melissa Berman; Catherine Anne Mazzola
Journal:  Surg Neurol Int       Date:  2015-06-25

Review 10.  Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity.

Authors:  Adán Pérez-Arredondo; Eduardo Cázares-Ramírez; Paul Carrillo-Mora; Marina Martínez-Vargas; Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Radamés Alemón-Medina; Aristides Sampieri; Luz Navarro; Liliana Carmona-Aparicio
Journal:  Clin Neuropharmacol       Date:  2016 Nov/Dec       Impact factor: 1.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.